Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Receivables" stands at 688.96 Billion Japanese Yens as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Net Receivables" stands at 688.96 Billion JPY. This represents an increase of 1.39 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.45 percent compared to the value the year prior.
The 1 year change in percent is -4.45.
The 3 year change in percent is -13.94.
The 5 year change in percent is -10.50.
The 10 year change in percent is 46.04.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Receivables | 280,205,508,085.11 |